Asparlas is used to treat acute lymphoblastic leukemia in children and young adults from 1 month to 21 years old. Asparlas may also be used for purposes not listed in this medication guide. Asparlas side effects Get emergency medical help if you have signs of an allergic reaction: hives, itching, redness;...
ASPARLAS is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years. The recommended dose of ASPARLAS is 2,500 units / m2 given intravenously no more frequently than every 21 days....
Asparlas Dosage Recommended Dosage The recommended dose of ASPARLAS is 2,500 units / m 2 given intravenously no more frequently than every 21 days. Recommended Premedication Premedicate patients with acetaminophen, an H-1 receptor blocker (such as diphenhydramine), and an H-2 receptor blocker (such...
Asparlas Interactions There are 414 drugs known to interact with Asparlas (calaspargase pegol), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 15 are major, and 399 are moderate. Does Asparlas interact with my other drugs? Enter medications to...
Asparlas Side Effects Serious side effects Other side effects Professional info FAQ Note: This document provides detailed information about Asparlas Side Effects associated with calaspargase pegol . Some dosage forms listed on this page may not apply specifically to the brand name Asparlas...
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Ponatinib is used to treat chronic myeloid leukemia and Philadelphia chromosome positive acute ...
Blinatumomab (Blincyto) is an injectable immunotherapy treatment that may be used to treat B-cell ...
Mercaptopurine is used for acute lymphoblastic leukemia, autoimmune hepatitis, crohn's disease ...
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Asparlas (Intravenous) Play pronunciation Uses Before taking Dosage Warnings Side effects Brand names FAQ Uses for Asparlas Calaspargase pegol-mknl injection is used together with other cancer medicines to treat patients with acute lymphoblastic leukemia (ALL), a type of white blood cell cancer...
Asparlas Alternatives Compared View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions. Asparlas (calaspargase pegol) Methotrexate Mercaptopurine Enter another drug to compare View side-by-side comparisons of medication uses, ratings, cost, side effects and...
Asparlas FDA Approval History Asparlas (calaspargase pegol-mknl) is an asparagine specific enzyme indicated as a componentof a multi-agent chemotherapy regimen for the treatment of acute lymphoblastic leukemia. Warnings and Precautions Patients and caregivers should be advised of the following...
Asparlas Prices, Coupons, Copay Cards & Patient Assistance Prices Coupons Patient assistance Asparlas ( calaspargase pegol ) is a member of the miscellaneous antineoplastics drug class and is commonly used for Acute Lymphoblastic Leukemia. Asparlas prices Intravenous Solution mknl 750 units / mL...
How does Asparlas (calaspargase pegol-mknl) compare to Oncaspar (pegaspargase)? Medically reviewed by Judith Stewart, BPharm . Last updated on March 19, 2025. Official Answer by Drugs.com Asparlas is given no more frequently than every 21 days and Oncaspar is given no more frequently than every 14...
